Sorasak Intorasoot | Microbiology | Innovative Research Award

Published on by Medical Lab Scientist

Innovative Research Award

Sorasak Intorasoot
Chiang Mai University, Thailand

Sorasak Intorasoot
Affiliation Chiang Mai University
Country Thailand
Scopus ID 6506991699
Documents 32
Citations 358
h-index 11
Subject Area Microbiology
Event Medical Lab Scientist Awards
ORCID 0000-0002-7137-4750

Sorasak Intorasoot is a researcher affiliated with Chiang Mai University whose scholarly activities are associated with microbiology and related biomedical laboratory sciences. His publication profile demonstrates sustained contributions to microbial research, laboratory investigations, and scientific dissemination. The documented publication output, citation performance, and h-index indicate measurable academic influence within his field and provide a basis for evaluating research excellence and suitability for professional recognition.[1][2]

Abstract

Sorasak Intorasoot has established a scholarly profile within microbiology through contributions that address microbial biology, laboratory investigations, and biomedical research applications. His publication record demonstrates consistent participation in scientific studies that advance understanding of microorganisms and their relevance to health sciences. With 32 indexed documents, 358 citations, and an h-index of 11, his work reflects measurable academic visibility and influence. The researcher’s contributions support evidence-based laboratory practices, interdisciplinary collaboration, and knowledge dissemination within microbiological sciences. These achievements collectively illustrate sustained research productivity and scientific engagement suitable for academic recognition and professional distinction.[1][2]

Keywords

Microbiology; Microbial Research; Biomedical Laboratory Science; Laboratory Diagnostics; Scientific Publications; Citation Impact; Academic Research; Infectious Diseases; Experimental Biology; Research Excellence.

Introduction

Microbiological research plays a fundamental role in advancing healthcare, diagnostics, and biological sciences. Sorasak Intorasoot has contributed to this domain through research activities documented in international scholarly databases. His academic record reflects ongoing engagement with laboratory-based investigations and scientific communication within microbiology and related health disciplines.[3]

Research Profile

Affiliated with Chiang Mai University, Sorasak Intorasoot maintains an established research profile characterized by peer-reviewed publications, citation activity, and interdisciplinary scientific collaborations. His documented scholarly output demonstrates active participation in microbiological studies and laboratory science investigations relevant to contemporary biomedical research.[1][2]

Research Contributions

The researcher has contributed to studies involving microbial systems, laboratory methodologies, and biomedical applications. His work supports scientific understanding of microorganisms and promotes evidence-based approaches in microbiology. These contributions have been disseminated through peer-reviewed publications and recognized through citation by the broader scientific community.[1]

Publications

The publication portfolio includes 32 indexed scholarly documents covering microbiology and associated biomedical topics. These works contribute to scientific literature through experimental findings, laboratory analyses, and collaborative investigations that support ongoing developments within microbial and health-related research fields.[1]

Research Impact

Research impact is reflected through 358 citations and an h-index of 11, indicating continued scholarly engagement with the researcher’s published work. Citation-based metrics suggest that his studies have contributed useful knowledge to microbiology and related scientific disciplines while maintaining visibility within academic literature.[1]

Award Suitability

The combination of sustained publication activity, documented citation influence, institutional affiliation, and contributions to microbiological science supports consideration for the Innovative Research Award. These accomplishments demonstrate research productivity, scientific relevance, and professional engagement aligned with the objectives of academic recognition programs.[1][4]

Conclusion

Sorasak Intorasoot’s scholarly record reflects meaningful participation in microbiology research and scientific communication. His publication output, citation performance, and institutional contributions collectively demonstrate academic engagement and research effectiveness, supporting recognition through professional awards that acknowledge scientific achievement and continued advancement of knowledge.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Sorasak Intorasoot, Author ID 6506991699. Scopus. https://www.scopus.com/authid/detail.uri?authorId=6506991699
  2. ORCID. (n.d.). ORCID record for Sorasak Intorasoot (0000-0002-7137-4750). https://orcid.org/0000-0002-7137-4750
  3. Kaewma, W., Thanoi, V., Butr-Indr, B., Wattananandkul, U., Phunpae, P., Sitthidet Tharinjaroen, C., Sangboonruang, S., Intorasoot, A., & Intorasoot, S. (2025). A survey of foodborne bacterial contamination in Chiang Mai Province, Thailand: A pilot study focused on Aeromonas and Vibrio. Journal of Associated Medical Sciences. https://he01.tci-thaijo.org/index.php/bulletinAMS/article/view/277078
  4. Medical Lab Scientist Awards. (n.d.). Award information and recognition criteria. https://medicallabscientist.com/

AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Project leader at Technical University of Munich, Germany

Prof. Dr. Awad A. Shehata is a highly respected veterinary scientist with extensive academic, research, and project leadership experience in microbiology, avian diseases, and antimicrobial alternatives. Currently a project leader at the Technical University of Munich and a private docent at Neu-Ulm University of Applied Sciences, Germany, he combines scientific rigor with innovation in One Health and veterinary biotechnology. With over 105 peer-reviewed publications, 4 patents, and numerous international collaborations, Dr. Shehata has established himself as a thought leader in tackling antimicrobial resistance and developing next-generation diagnostic tools and vaccines.

profile

orcid

Education

Dr. Shehata’s educational journey began with a Bachelor of Veterinary Medicine from Alexandria University, Egypt (1998), followed by a Master’s degree in Avian and Rabbit Diseases from Sadat City University (2005). He obtained his Ph.D. in Veterinary Medicine from Leipzig University, Germany (2011), focusing on truncated influenza sequences for vaccination. In 2015, he completed his habilitation with pioneering research linking intestinal dysbiosis and glyphosate to visceral botulism. He later earned advanced certifications, including Dipl. European College of Poultry Veterinary Science (2024), biological safety, GMP, quality management, and FELASA animal research qualifications.

Experience

Spanning over two decades, Dr. Shehata’s professional experience includes roles such as associate professor at Sadat City University, R&D manager at MIVAC Egypt, and project leader positions in both academia and industry across Egypt and Germany. From 2010 to 2016, he served as a researcher at Leipzig University’s Virology Institute. Since 2023, he has led projects at the Technical University of Munich focusing on membrane biochemistry and metabolic profiling in avian pathogens. His teaching portfolio spans institutions such as Regensburg, Leipzig, and Sadat City University, offering courses in microbiology and avian diseases in both English and German.

Research Interest

Dr. Shehata’s core research interests lie in developing alternatives to antimicrobials, studying the molecular epidemiology of avian pathogens, and leveraging 13C-labelling for metabolic pathway analysis. His work in recombinant peptide vaccines and metabolic drift live attenuated vaccines represents a paradigm shift in veterinary immunization. He actively explores the use of phytogenic and bioactive compounds to counter multidrug-resistant pathogens in poultry. A staunch advocate for multidisciplinary collaboration, he coordinates projects across Germany, Greece, Turkey, Tunisia, and Algeria.

Award

Dr. Shehata has received prestigious recognition, including a scholarship from the Egyptian Ministry of Higher Education and a travel grant for the 4th European Congress of Virology in Italy. His leadership in the PRIMA Project (1.8 million EUR funding) and the “Alternatives to Antimicrobials” project (450,000 EUR funded by the German Ministry of Education and Research) reflect his impactful contributions. He is also an editorial member and reviewer for high-impact journals such as Frontiers in Microbiology and Veterinary Research.

Publication

Dr. Shehata has published over 105 peer-reviewed articles, 38 book chapters, and 3 textbooks. Here are 7 selected publications:

Shehata AA, et al. (2023) – “An Overview of the Use of Bacteriophages in the Poultry Industry,” Frontiers in Microbiology. Cited by 30 articles.

Shehata AA, et al. (2022) – “Diversity of Coronaviruses with Attention to SARS-CoV-2,” Animals. Cited by 20 articles.

Shehata AA, et al. (2020) – “Salmonella Enteritidis Vaccine Candidate,” Heliyon. Cited by 18 articles.

Shehata AA, et al. (2020) – “COVID-19 Pandemic Review,” J Clin Med. Cited by 55 articles.

Shehata AA, et al. (2022) – “Probiotics for Gut Health in Poultry,” Microorganisms. Cited by 27 articles.

Shehata AA, et al. (2021) – “Evolution of SARS-CoV-2 Furin Cleavage Sites,” Archives of Virology. Cited by 19 articles.

Shehata AA, et al. (2015) – “Development of Broadly Reactive H5N1 Vaccine,” Vaccine. Cited by 40 articles.

Conclusion

Prof. Dr. Awad A. Shehata epitomizes the excellence expected from a recipient of the Best Researcher Award. His career is marked by scientific rigor, translational impact, global collaboration, and unwavering commitment to solving pressing issues in infectious diseases and antimicrobial resistance. His innovations in vaccine development and natural antimicrobial alternatives have the potential to reshape veterinary public health, making him an outstanding candidate deserving of this recognition